Correlation Between Edgewise Therapeutics and Ocular Therapeutix
Can any of the company-specific risk be diversified away by investing in both Edgewise Therapeutics and Ocular Therapeutix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Edgewise Therapeutics and Ocular Therapeutix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Edgewise Therapeutics and Ocular Therapeutix, you can compare the effects of market volatilities on Edgewise Therapeutics and Ocular Therapeutix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Edgewise Therapeutics with a short position of Ocular Therapeutix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Edgewise Therapeutics and Ocular Therapeutix.
Diversification Opportunities for Edgewise Therapeutics and Ocular Therapeutix
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Edgewise and Ocular is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and Ocular Therapeutix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocular Therapeutix and Edgewise Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Edgewise Therapeutics are associated (or correlated) with Ocular Therapeutix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocular Therapeutix has no effect on the direction of Edgewise Therapeutics i.e., Edgewise Therapeutics and Ocular Therapeutix go up and down completely randomly.
Pair Corralation between Edgewise Therapeutics and Ocular Therapeutix
Given the investment horizon of 90 days Edgewise Therapeutics is expected to under-perform the Ocular Therapeutix. But the stock apears to be less risky and, when comparing its historical volatility, Edgewise Therapeutics is 1.13 times less risky than Ocular Therapeutix. The stock trades about -0.05 of its potential returns per unit of risk. The Ocular Therapeutix is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 835.00 in Ocular Therapeutix on December 29, 2024 and sell it today you would lose (60.00) from holding Ocular Therapeutix or give up 7.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Edgewise Therapeutics vs. Ocular Therapeutix
Performance |
Timeline |
Edgewise Therapeutics |
Ocular Therapeutix |
Edgewise Therapeutics and Ocular Therapeutix Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Edgewise Therapeutics and Ocular Therapeutix
The main advantage of trading using opposite Edgewise Therapeutics and Ocular Therapeutix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Edgewise Therapeutics position performs unexpectedly, Ocular Therapeutix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will offset losses from the drop in Ocular Therapeutix's long position.Edgewise Therapeutics vs. Century Therapeutics | Edgewise Therapeutics vs. C4 Therapeutics | Edgewise Therapeutics vs. Mineralys Therapeutics, Common | Edgewise Therapeutics vs. Cullinan Oncology LLC |
Ocular Therapeutix vs. CytomX Therapeutics | Ocular Therapeutix vs. Assembly Biosciences | Ocular Therapeutix vs. Spero Therapeutics | Ocular Therapeutix vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |